From preclinical and clinical drug development plans up to proof of concept

Aepodia provides clinical due diligence support  for preclinical pharmacology data to phase II clinical data to evaluate the:

  • pertinence of the available preclinical and clinical data;
  • interpretation of the available compound information;
  • level of quality and regulatory compliance; and
  • robustness of the IP.

We present our results in a technical report that includes a SWOT analysis.

We draw on a network of consultants and experts in toxicology, preclinical drug metabolism, chemistry, GLP, GMP and more to ensure effective and complete due diligence.